マイクロバブル/超音波造影剤の市場規模、シェア、成長分析：製品タイプ別、適用領域別、エンドユーザー別、投与経路別、地域別 - 産業予測 2025～2032年

マイクロバブル/超音波造影剤の世界市場規模は、2023年に25億米ドルと評価され、2024年の26億2,000万米ドルから2032年には37億5,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは4.6%で成長する見通しです。

医療画像分野では、造影剤、特にマイクロバブルは、診断処置中に液体や構造の可視性を高める上で極めて重要な役割を果たしています。放射線学や循環器学で使用されるこれらのマイクロバブル造影剤は、血液プール剤として機能し、遺伝子治療や分子イメージングなどの用途に役立っています。疾患特異的なリガンドを利用することで、マイクロバブルは血管バイオマーカーの同定、炎症のモニタリング、腫瘍血管系の評価を行うことができます。静脈内に注入されると、これらの薬剤は赤血球を模倣し、超音波周波数に反応してサイズを変化させ、標的組織領域から強いエコーを発生させる。このエコー源性の増大は超音波分解能を向上させ、より鮮明で情報量の多い心エコー図をもたらし、医療画像診断における診断精度と患者の転帰を向上させる。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

マイクロバブル/超音波造影剤市場規模：製品タイプ別& CAGR（2025-2032）

• 市場概要
• Definity
• Optison
• Sonovue
• Lumason
• その他

マイクロバブル/超音波造影剤市場規模：適応領域別& CAGR（2025-2032）

• 市場概要
• 心臓病学
• 腫瘍学
• 婦人科
• その他

マイクロバブル/超音波造影剤市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院
• 画像診断センター
• 専門クリニック
• 調査・学術機関

マイクロバブル/超音波造影剤市場規模：投与経路別& CAGR（2025-2032）

• 市場概要
• 静脈内
• 血管内
• 動脈内
• その他

マイクロバブル/超音波造影剤市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Bracco Imaging S.p.A.（Italy）
• GE Healthcare（USA）
• Lantheus Holdings, Inc.（USA）
• FUJIFILM VisualSonics, Inc.（Canada）
• Siemens Healthineers AG（Germany）
• Canon Medical Systems Corporation（Japan）
• Samsung Medison Co., Ltd.（South Korea）
• Mindray Bio-Medical Electronics Co., Ltd.（China）
• Philips Healthcare（Netherlands）
• Advanced Microbubbles Laboratories B.V.（Netherlands）
• Targeson, Inc.（USA）
• VisualSonics（Canada）
• NanoMedical Diagnostics, Inc.（USA）
• Medtron AG（Germany）
• Insightec Ltd.（Israel）
• SuperSonic Imagine S.A.（France）
• Telemed Ultrasound Systems（Lithuania）

結論と提言

Global Microbubbles/Ultrasound Contrast Agents Market size was valued at USD 2.5 billion in 2023 and is poised to grow from USD 2.62 billion in 2024 to USD 3.75 billion by 2032, growing at a CAGR of 4.6% during the forecast period (2025-2032).

In the medical imaging sector, contrast media, particularly microbubbles, play a pivotal role in enhancing the visibility of fluids and structures during diagnostic procedures. Employed in radiology and cardiology, these microbubble contrast agents serve as blood pool agents and are instrumental in applications including gene therapy and molecular imaging. Utilizing disease-specific ligands, microbubbles can identify vascular biomarkers, monitor inflammation, and evaluate tumor vasculature. When injected intravenously, these agents mimic red blood cells, responding to ultrasound frequencies by altering their size and producing strong echoes from targeted tissue areas. This increased echogenicity improves ultrasound resolution, resulting in clearer and more informative echocardiograms, thus advancing diagnostic accuracy and patient outcomes in medical imaging.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microbubbles/Ultrasound Contrast Agents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microbubbles/Ultrasound Contrast Agents Market Segments Analysis

Global Microbubbles/Ultrasound Contrast Agents Market is segmented by Product Type, Application Area, End-user, Route of Administration and region. Based on Product Type, the market is segmented into Definity, Optison, Sonovue, Lumason and Others. Based on Application Area, the market is segmented into Cardiology, Oncology, Gynecology and Others. Based on End-user, the market is segmented into Hospitals, Diagnostic Imaging Centers, Specialty Clinics and Research and Academic Institutes. Based on Route of Administration, the market is segmented into Intravenous, Intravascular, Intra-arterial and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Microbubbles/Ultrasound Contrast Agents Market

The Global Microbubbles and Ultrasound Contrast Agents market is gaining momentum due to several key factors. The increasing demand for targeted therapies and the necessity to track biomarker progression within the vascular endothelium are fueling the adoption of these technologies in molecular imaging. Additionally, advancements in ultrasound technology, coupled with a rising demand for precise diagnostic tools, are expected to drive the market forward during the forecast period. The superior benefits offered by microbubbles and ultrasound contrast agents compared to traditional diagnostic methods, alongside a growing prevalence of chronic diseases, are also contributing significantly to the market's anticipated growth trajectory.

Restraints in the Global Microbubbles/Ultrasound Contrast Agents Market

The global market for microbubbles and ultrasound contrast agents faces a significant challenge due to the relatively short lifespan of microbubbles, which poses a considerable limitation on their effectiveness and application. This inherent drawback is likely to hinder the growth and development of the market throughout the forecast period, as the limited duration of microbubble functionality can impact their usability in medical imaging and diagnostics. As a result, the industry may experience slowed progress and reduced adoption rates for these technologies unless solutions are found to enhance the stability and longevity of microbubbles in clinical settings.

Market Trends of the Global Microbubbles/Ultrasound Contrast Agents Market

The global microbubbles/ultrasound contrast agents market is witnessing a significant trend towards the integration of advanced molecular imaging capabilities, particularly in the fields of cardiology and radiology. As the technology evolves, microbubbles are increasingly being recognized not just as blood-pool agents but as versatile targeted agents capable of binding to disease-specific molecular markers through functionalization. This advancement allows for enhanced visualization of critical clinical conditions, such as tumor vasculature, vascular endothelium biomarker status, and inflammatory responses associated with ischemia-reperfusion injuries. Consequently, the market is poised for growth, driven by rising demand for precision diagnostics and personalized medicine.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Microbubbles/Ultrasound Contrast Agents Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Definity
• Optison
• Sonovue
• Lumason
• Others

Global Microbubbles/Ultrasound Contrast Agents Market Size by Application Area & CAGR (2025-2032)

• Market Overview
• Cardiology
• Oncology
• Gynecology
• Others

Global Microbubbles/Ultrasound Contrast Agents Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Imaging Centers
• Specialty Clinics
• Research and Academic Institutes

Global Microbubbles/Ultrasound Contrast Agents Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Intravenous
• Intravascular
• Intra-arterial
• Others

Global Microbubbles/Ultrasound Contrast Agents Market Size & CAGR (2025-2032)

• North America (Product Type, Application Area, End-user, Route of Administration)
  • US
  • Canada
• Europe (Product Type, Application Area, End-user, Route of Administration)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application Area, End-user, Route of Administration)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application Area, End-user, Route of Administration)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application Area, End-user, Route of Administration)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Bracco Imaging S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lantheus Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM VisualSonics, Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung Medison Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Bio-Medical Electronics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Microbubbles Laboratories B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Targeson, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VisualSonics (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NanoMedical Diagnostics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtron AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insightec Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SuperSonic Imagine S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Telemed Ultrasound Systems (Lithuania)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations